WASHINGTON – In a letter to U.S. Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock, Sens. Chuck Grassley (R-Iowa) and …
Full story here.
Published by www.grassley.senate.gov
Visited 1 times, 1 visit(s) today
January 25, 2022• byQuorum Call
WASHINGTON – In a letter to U.S. Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock, Sens. Chuck Grassley (R-Iowa) and …